{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T05:06:08Z","timestamp":1765515968371,"version":"3.48.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100014355","name":"Nirma University","doi-asserted-by":"publisher","award":["NU\/Ph.D\/Major Res Pro\/IT-NU\/21-22\/1441"],"award-info":[{"award-number":["NU\/Ph.D\/Major Res Pro\/IT-NU\/21-22\/1441"]}],"id":[{"id":"10.13039\/501100014355","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Genet Genomics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00438-025-02328-5","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T03:50:55Z","timestamp":1765511455000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ATR&RNASEL germline variants: novel findings in a case of familial cancer"],"prefix":"10.1007","volume":"301","author":[{"given":"Shristi","family":"Biswas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhruvi","family":"Vihol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swati","family":"Manekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3562-3375","authenticated-orcid":false,"given":"Sonal","family":"Bakshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"issue":"1","key":"2328_CR1","first-page":"7","volume":"76","author":"I Adzhubei","year":"2013","unstructured":"Adzhubei I, Jordan DM, Sunyaev SR (2013) Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet 76(1):7\u201320","journal-title":"Curr Protoc Hum Genet"},{"issue":"1","key":"2328_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-019-0110-y","volume":"5","author":"FS AlHarthi","year":"2020","unstructured":"AlHarthi FS, Qari A, Edress A, Abedalthagafi M (2020) Familial\/inherited cancer syndrome: a focus on the highly consanguineous Arab population. NPJ Genom Med 5(1):3","journal-title":"NPJ Genom Med"},{"issue":"5","key":"2328_CR3","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/ijc.21254","volume":"117","author":"DK Bartsch","year":"2005","unstructured":"Bartsch DK et al (2005) RNASEL germline variants are associated with pancreatic cancer. Int J Cancer 117(5):718\u2013722","journal-title":"Int J Cancer"},{"issue":"7\u20138","key":"2328_CR4","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.bbapap.2019.05.002","volume":"1867","author":"SK Beaver","year":"2019","unstructured":"Beaver SK et al (2019) NQO1: a target for the treatment of cancer and neurological diseases, and a model to understand loss of function disease mechanisms. Biochimica et Biophysica Acta (BBA) 1867(7\u20138):663\u2013676","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"15","key":"2328_CR5","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1016\/j.ejca.2010.06.116","volume":"46","author":"C Bilbao","year":"2010","unstructured":"Bilbao C et al (2010) Double strand break repair components are frequent targets of microsatellite instability in endometrial cancer. Eur J Cancer 46(15):2821\u20132827","journal-title":"Eur J Cancer"},{"issue":"6","key":"2328_CR6","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.31557\/APJCP.2023.24.6.2129","volume":"24","author":"S Biswas","year":"2023","unstructured":"Biswas S, Manekar S, Bakshi SR (2023) A case study on PPM1D and 9 other shared germline alterations in a family. Asian Pac J Cancer Prev 24(6):2129","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"2328_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12041-024-01481-x","volume":"103","author":"S Biswas","year":"2024","unstructured":"Biswas S et al (2024) Germline genetic variants in a case of familial cancer: RAD51D and four other co-segregated variants. J Genet 103(2):31","journal-title":"J Genet"},{"issue":"3","key":"2328_CR8","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"2328_CR9","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/ng1021","volume":"32","author":"G Casey","year":"2002","unstructured":"Casey G et al (2002) RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nat Genet 32(4):581\u2013583","journal-title":"Nat Genet"},{"key":"2328_CR68","doi-asserted-by":"crossref","unstructured":"Madsen BE, et al. (2008) Germline mutation in RNASEL predicts increased risk of head and neck, uterine cervix and breast cancer. PLoS One. 3(6):e2492","DOI":"10.1371\/journal.pone.0002492"},{"issue":"8","key":"2328_CR10","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.7314\/APJCP.2014.15.8.3811","volume":"15","author":"Y Chen","year":"2014","unstructured":"Chen Y et al (2014) Nitric oxide synthase 3 gene variants and colorectal cancer: a meta-analysis. Asian Pac. J. Cancer Prev. 15(8):3811\u20133815","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"1","key":"2328_CR11","first-page":"82","volume":"40","author":"WL DeLano","year":"2002","unstructured":"DeLano WL (2002) Pymol: an open-source molecular graphics tool. CCP4 Newsl. Protein Crystallogr. 40(1):82\u201392","journal-title":"CCP4 Newsl. Protein Crystallogr."},{"issue":"10","key":"2328_CR12","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1089\/cmb.2005.12.1275","volume":"12","author":"DM Dunlavy","year":"2005","unstructured":"Dunlavy DM et al (2005) HOPE: a homotopy optimization method for protein structure prediction. J. Comput. Biol. 12(10):1275\u20131288","journal-title":"J. Comput. Biol."},{"key":"2328_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-6-230","volume":"6","author":"F Durocher","year":"2006","unstructured":"Durocher F et al (2006) Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast\/ovarian cancer families. BMC Cancer 6:1\u201321","journal-title":"BMC Cancer"},{"issue":"2","key":"2328_CR14","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1042\/bj1870429","volume":"187","author":"YH Edwards","year":"1980","unstructured":"Edwards YH, Potter J, Hopkinson DA (1980) Human FAD-dependent NAD (P) H diaphorase. Biochem J 187(2):429\u2013436","journal-title":"Biochem J"},{"issue":"7","key":"2328_CR15","first-page":"1439","volume":"54","author":"P Eickelmann","year":"1994","unstructured":"Eickelmann P et al (1994) A genetic polymorphism of NAD(P)H:quinone oxidoreductase (NQO1) associated with altered enzyme activity and benzene toxicity in exposed populations. Cancer Res 54(7):1439\u20131443","journal-title":"Cancer Res"},{"key":"2328_CR67","doi-asserted-by":"crossref","unstructured":"Landrum MJ, Lee JM, Benson M, Brown G, Chao C, Chitipiralla S, et al. (2016) ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Research. 44(D1):D862-D868.","DOI":"10.1093\/nar\/gkv1222"},{"issue":"8","key":"2328_CR17","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/humu.24309","volume":"43","author":"S Gudmundsson","year":"2022","unstructured":"Gudmundsson S et al (2022) Variant interpretation using population databases: lessons from gnomAD. Hum Mutat 43(8):1012\u20131030","journal-title":"Hum Mutat"},{"key":"2328_CR18","doi-asserted-by":"crossref","unstructured":"Hade IM, Al-Khafaji AS, Lafta FM (2024) Involvement of Total Antioxidant Activity and eNOS Gene rs1799983\/rs2070744 Polymorphisms in Breast Carcinogenesis. IJS 65(3):1297\u20131309","DOI":"10.24996\/ijs.2024.65.3.11"},{"key":"2328_CR19","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/s12282-016-0750-z","volume":"24","author":"Z Hallajian","year":"2017","unstructured":"Hallajian Z, Mahjoubi F, Nafissi N (2017) Simultaneous ATM\/BRCA1\/RAD51 expression variations associated with prognostic factors in Iranian sporadic breast cancer patients. J Breast Cancer 24:624\u2013634","journal-title":"J Breast Cancer"},{"key":"2328_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/bcr1037","volume":"7","author":"K Heikkinen","year":"2005","unstructured":"Heikkinen K et al (2005) Mutation analysis of the ATR gene in breast and ovarian cancer families. Breast Cancer Res 7:1\u20137","journal-title":"Breast Cancer Res"},{"issue":"8","key":"2328_CR21","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1093\/carcin\/bgi360","volume":"27","author":"K Heikkinen","year":"2006","unstructured":"Heikkinen K, Rapakko K, Karppinen SM et al (2006) RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability. Carcinogenesis 27(8):1593\u20131599","journal-title":"Carcinogenesis"},{"key":"2328_CR22","doi-asserted-by":"crossref","unstructured":"Holcomb N et al (2022) ATR-I774Yfs* 5 promotes genomic instability through micronuclei formation. bioRxiv 2022-03","DOI":"10.1101\/2022.03.10.483800"},{"key":"2328_CR23","unstructured":"https:\/\/www.ncbi.nlm.nih.gov\/gene\/?term=ATR"},{"key":"2328_CR24","unstructured":"https:\/\/www.ncbi.nlm.nih.gov\/clinvar\/variation\/14015\/"},{"key":"2328_CR25","unstructured":"https:\/\/www.ncbi.nlm.nih.gov\/clinvar\/variation\/16809\/"},{"key":"2328_CR26","unstructured":"https:\/\/www.mycancergenome.org\/content\/gene\/ATR\/"},{"issue":"2","key":"2328_CR27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.molcel.2013.12.025","volume":"53","author":"H Huang","year":"2014","unstructured":"Huang H et al (2014) Dimeric structure of pseudokinase RNase L bound to 2-5A reveals a basis for interferon-induced antiviral activity. Mol Cell 53(2):221\u2013234","journal-title":"Mol Cell"},{"key":"2328_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.856452","volume":"12","author":"R Huang","year":"2022","unstructured":"Huang R et al (2022) Lynch syndrome-associated endometrial cancer with combined EPCAM-MSH2 deletion: a case report. Front Oncol 12:856452","journal-title":"Front Oncol"},{"issue":"12","key":"2328_CR29","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.7150\/jca.33192","volume":"10","author":"WC Hung","year":"2019","unstructured":"Hung WC et al (2019) Involvement of endothelial nitric oxide synthase gene variants in the aggressiveness of uterine cervical cancer. J Cancer 10(12):2594","journal-title":"J Cancer"},{"key":"2328_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.568786","volume":"10","author":"MSN Kadri","year":"2021","unstructured":"Kadri MSN et al (2021) Mutational landscape for Indian hereditary breast and ovarian cancer cohort suggests need for identifying population specific genes and biomarkers for screening. Front Oncol 10:568786","journal-title":"Front Oncol"},{"issue":"1","key":"2328_CR31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/ijc.30373","volume":"140","author":"HJ Kim","year":"2017","unstructured":"Kim HJ et al (2017) Anti-tumor activity of the ATR inhibitor AZD6738 in HER2 positive breast cancer cells. Int J Cancer 140(1):109\u2013119","journal-title":"Int J Cancer"},{"key":"2328_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.920390","volume":"13","author":"R Kingdom","year":"2022","unstructured":"Kingdom R, Wright CF (2022) Incomplete penetrance and variable expressivity: from clinical studies to population cohorts. Front Genet 13:920390","journal-title":"Front Genet"},{"key":"2328_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/0471142905.hg0720s76","author":"H Kobayashi","year":"2013","unstructured":"Kobayashi H (2013) Hereditary breast and ovarian cancer susceptibility genes, including BRCA1 and BRCA2, and other DNA repair genes such as RAD50, TP53, PALB2, CHEK2, and RAD51D, contribute to breast and ovarian cancer risk through genomic instability mechanisms. Curr Protoc Hum Genet. https:\/\/doi.org\/10.1002\/0471142905.hg0720s76","journal-title":"Curr Protoc Hum Genet"},{"issue":"2","key":"2328_CR34","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.clnu.2011.08.011","volume":"31","author":"SA Lee","year":"2012","unstructured":"Lee SA et al (2012) Combined effects of antioxidant vitamin and NOS3 genetic polymorphisms on breast cancer risk in a Korean population. Clin Nutr 31(2):204\u2013211. https:\/\/doi.org\/10.1016\/j.clnu.2011.08.011","journal-title":"Clin Nutr"},{"issue":"7","key":"2328_CR35","doi-asserted-by":"publisher","first-page":"e68578","DOI":"10.1371\/journal.pone.0068578","volume":"8","author":"WY Lin","year":"2013","unstructured":"Lin WY et al (2013) Associations of ATR and CHEK1 single nucleotide polymorphisms with breast cancer. PLoS One 8(7):e68578","journal-title":"PLoS One"},{"issue":"6","key":"2328_CR36","doi-asserted-by":"publisher","first-page":"e2492","DOI":"10.1371\/journal.pone.0002492","volume":"3","author":"BE Madsen","year":"2008","unstructured":"Madsen BE et al (2008) Germline mutation in RNASEL predicts increased risk of head and neck, uterine cervix and breast cancer. PLoS One 3(6):e2492","journal-title":"PLoS One"},{"issue":"W1","key":"2328_CR37","doi-asserted-by":"publisher","first-page":"W274","DOI":"10.1093\/nar\/gkad297","volume":"51","author":"LJ McGuffin","year":"2023","unstructured":"McGuffin LJ et al (2023) Prediction of protein structures, functions and interactions using the IntFOLD7, MultiFOLD and ModFOLDdock servers. Nucleic Acids Res 51(W1):W274\u2013W280","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2328_CR38","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren W et al (2016) The ensembl variant effect predictor. Genome Biol 17(1):122","journal-title":"Genome Biol"},{"issue":"9","key":"2328_CR39","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1093\/carcin\/bgq132","volume":"31","author":"MS Meyer","year":"2010","unstructured":"Meyer MS et al (2010) Genetic variation in RNASEL associated with prostate cancer risk and progression. Carcinogenesis 31(9):1597\u20131603","journal-title":"Carcinogenesis"},{"key":"2328_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.niox.2018.12.006","volume":"84","author":"J Nan","year":"2019","unstructured":"Nan J et al (2019) Effects of eNOS gene polymorphisms on individual susceptibility to cancer: a meta-analysis. Nitric Oxide 84:1\u20136","journal-title":"Nitric Oxide"},{"issue":"26","key":"2328_CR41","doi-asserted-by":"publisher","first-page":"16510","DOI":"10.1073\/pnas.262701999","volume":"99","author":"PI Nedvetsky","year":"2002","unstructured":"Nedvetsky PI, Sessa WC, Schmidt HHW (2002) There\u2019s NO binding like NOS binding: protein\u2013protein interactions in NO\/cGMP signaling. Proc Natl Acad Sci USA 99(26):16510\u201316512","journal-title":"Proc Natl Acad Sci USA"},{"issue":"13","key":"2328_CR42","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1093\/nar\/gkg509","volume":"31","author":"PC Ng","year":"2003","unstructured":"Ng PC, Henikoff S (2003) SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res 31(13):3812\u20133814","journal-title":"Nucleic Acids Res"},{"key":"2328_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-018-4028-z","volume":"18","author":"T Nguyen-Dumont","year":"2018","unstructured":"Nguyen-Dumont T et al (2018) Is RNASEL: p. Glu265* a modifier of early-onset breast cancer risk for carriers of high-risk mutations? BMC Cancer 18:1\u20137","journal-title":"BMC Cancer"},{"issue":"9","key":"2328_CR44","first-page":"1","volume":"12","author":"M Panara","year":"2024","unstructured":"Panara M, Tulshyan V (2024) Diagnosis and detection of pancreatic cancer using advanced learning models and explainable artificial intelligence. Int J Creative Res Thoughts 12(9):1\u201319","journal-title":"Int J Creative Res Thoughts"},{"issue":"10","key":"2328_CR45","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1038\/sj.bjc.6601756","volume":"90","author":"HS Patmore","year":"2004","unstructured":"Patmore HS et al (2004) Can a genetic signature for metastatic head and neck squamous cell carcinoma be characterised by comparative genomic hybridisation? Br J Cancer 90(10):1976\u20131982","journal-title":"Br J Cancer"},{"issue":"1","key":"2328_CR46","doi-asserted-by":"publisher","first-page":"5918","DOI":"10.1038\/s41467-020-19669-x","volume":"11","author":"V Pejaver","year":"2020","unstructured":"Pejaver V et al (2020) Inferring the molecular and phenotypic impact of amino acid variants with MutPred2. Nat Commun 11(1):5918","journal-title":"Nat Commun"},{"issue":"3","key":"2328_CR47","first-page":"203","volume":"4","author":"T Rajkumar","year":"2003","unstructured":"Rajkumar T, Soumittra N, Nancy NK, Swaminathan R, Sridevi V, Shanta V (2003) BRCA1, BRCA2 and CHEK2 (1100 Del C) germline mutations in hereditary breast and ovarian cancer families in South India. Asian Pac J Cancer Prev 4(3):203\u2013208","journal-title":"Asian Pac J Cancer Prev"},{"key":"2328_CR66","doi-asserted-by":"crossref","unstructured":"Roa BB, Boyd AA, Volcik K, Richards CS. (1996) Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nature Genetics. 14(2):185-187","DOI":"10.1038\/ng1096-185"},{"key":"2328_CR48","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/cr.2017.158","volume":"28","author":"Q Rao","year":"2018","unstructured":"Rao Q et al (2018) Cryo-EM structure of human ATR-ATRIP complex. Cell Res 28:143\u2013156","journal-title":"Cell Res"},{"issue":"4","key":"2328_CR49","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1086\/342775","volume":"71","author":"H Rennert","year":"2002","unstructured":"Rennert H et al (2002) A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews. Am J Hum Genet 71(4):981\u2013984","journal-title":"Am J Hum Genet"},{"issue":"D1","key":"2328_CR50","doi-asserted-by":"publisher","first-page":"D886","DOI":"10.1093\/nar\/gky1016","volume":"47","author":"P Rentzsch","year":"2019","unstructured":"Rentzsch P et al (2019) CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res 47(D1):D886\u2013D894","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2328_CR51","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/pro.3942","volume":"30","author":"CHM Rodrigues","year":"2021","unstructured":"Rodrigues CHM, Pires DEV, Ascher DB (2021) DynaMut2: assessing changes in stability and flexibility upon single and multiple point missense mutations. Protein Sci 30(1):60\u201369","journal-title":"Protein Sci"},{"issue":"5","key":"2328_CR52","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1086\/340450","volume":"70","author":"A R\u00f6kman","year":"2002","unstructured":"R\u00f6kman A et al (2002) Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer. Am J Hum Genet 70(5):1299\u20131304","journal-title":"Am J Hum Genet"},{"key":"2328_CR53","doi-asserted-by":"crossref","unstructured":"Safran M, Dalah I, Alexander J, Rosen N, Iny Stein T, Shmoish M et al (2010a) GeneCards Version 3: the human gene integrator. Database 2010:baq020","DOI":"10.1093\/database\/baq020"},{"key":"2328_CR54","doi-asserted-by":"crossref","unstructured":"Safran M et al (2010b) GeneCards Version 3: the human gene integrator. Database 2010:baq020","DOI":"10.1093\/database\/baq020"},{"issue":"45","key":"2328_CR55","doi-asserted-by":"publisher","first-page":"598","DOI":"10.4103\/ijmr.ijmr_1821_22","volume":"156","author":"K Sathishkumar","year":"2022","unstructured":"Sathishkumar K, Chaturvedi M, Das P, Stephen S, Mathur P (2022) Cancer incidence estimates for 2022 & projection for 2025: result from National cancer registry programme, India. Indian J Med Res 156(45):598\u2013607","journal-title":"Indian J Med Res"},{"key":"2328_CR65","doi-asserted-by":"crossref","unstructured":"Shihab HA, et al. (2014) Ranking non-synonymous single nucleotide polymorphisms based on disease concepts. Human Genomics. 8(1):11.","DOI":"10.1186\/1479-7364-8-11"},{"issue":"W1","key":"2328_CR56","doi-asserted-by":"publisher","first-page":"W446","DOI":"10.1093\/nar\/gkab266","volume":"49","author":"R Steinhaus","year":"2021","unstructured":"Steinhaus R et al (2021) MutationTaster2021. Nucleic Acids Res 49(W1):W446\u2013W451","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"2328_CR57","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.3390\/cancers11121913","volume":"11","author":"M Takeuchi","year":"2019","unstructured":"Takeuchi M et al (2019) Anti-tumor effect of inhibition of DNA damage response proteins, ATM and ATR, in endometrial cancer cells. Cancers 11(12):1913","journal-title":"Cancers"},{"issue":"20","key":"2328_CR58","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.1038\/sj.emboj.7600420","volume":"23","author":"N Tanaka","year":"2004","unstructured":"Tanaka N et al (2004) Structural basis for recognition of 2\u2032, 5\u2032-linked oligoadenylates by human ribonuclease L. EMBO J 23(20):3929\u20133938","journal-title":"EMBO J"},{"issue":"1","key":"2328_CR59","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1093\/biolre\/ioaa157","volume":"104","author":"SM Toprani","year":"2021","unstructured":"Toprani SM, Kelkar Mane V (2021) Role of DNA damage and repair mechanisms in uterine fibroid\/leiomyomas: a review. Biol Reprod 104(1):58\u201370","journal-title":"Biol Reprod"},{"key":"2328_CR60","doi-asserted-by":"publisher","DOI":"10.3892\/or.2014.3685","author":"MT Vietri","year":"2015","unstructured":"Vietri MT et al (2015) Analysis of PALB2 mutations in Italian patients with hereditary breast and ovarian cancers revealed novel truncating and missense variants, including c.1919C\u2009>\u2009A (p.S640X) and c.3047T\u2009>\u2009C (p.F1016S), highlighting their potential clinical relevance. Oncol Rep. https:\/\/doi.org\/10.3892\/or.2014.3685","journal-title":"Oncol Rep"},{"issue":"1","key":"2328_CR61","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.cancergencyto.2010.03.006","volume":"200","author":"K Wang","year":"2010","unstructured":"Wang K et al (2010) Interaction between BRCA1\/BRCA2 and ATM\/ATR associate with breast cancer susceptibility in a Chinese Han population. Cancer Genet Cytogenet 200(1):40\u201346","journal-title":"Cancer Genet Cytogenet"},{"issue":"20","key":"2328_CR62","first-page":"6795","volume":"63","author":"Y Xiang","year":"2003","unstructured":"Xiang Y et al (2003) Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2\u2032, 5\u2032-oligoadenylates. Cancer Res 63(20):6795\u20136801","journal-title":"Cancer Res"},{"issue":"1\u20132","key":"2328_CR63","first-page":"121","volume":"402","author":"T Yagi","year":"1998","unstructured":"Yagi T (1998) Molecular basis for the functions of NAD(P)H:quinone oxidoreductase in detoxification and chemoprevention. Mutat Res 402(1\u20132):121\u2013129","journal-title":"Mutat Res"},{"issue":"19","key":"2328_CR64","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1200\/JCO.2008.19.9802","volume":"27","author":"I Zighelboim","year":"2009","unstructured":"Zighelboim I et al (2009) ATR mutation in endometrioid endometrial cancer is associated with poor clinical outcomes. J Clin Oncol 27(19):3091\u20133096","journal-title":"J Clin Oncol"}],"container-title":["Molecular Genetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-025-02328-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00438-025-02328-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-025-02328-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T05:02:36Z","timestamp":1765515756000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00438-025-02328-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2328"],"URL":"https:\/\/doi.org\/10.1007\/s00438-025-02328-5","relation":{},"ISSN":["1617-4615","1617-4623"],"issn-type":[{"type":"print","value":"1617-4615"},{"type":"electronic","value":"1617-4623"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Institutional Ethical Committee (IEC) was obtained for the research work (IEC\/NU\/20\/IS\/3\/16th December 2020).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants in the study for blood collection and whole exome sequencing.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"7"}}